COMPARISON OF TREATMENT RETENTION OF SECUKINUMAB AND TNF-INHIBITORS IN PSORIATIC ARTHRITIS. OBSERVATIONAL DATA FROM A NORDIC COLLABORATION.

被引：0

作者：

Lindstrom, U. ^{[1
]}

Glintborg, B. ^{[2
,3
]}

Di Giuseppe, D. ^{[4
]}

Jorgensen, T. Schjodt ^{[5
]}

Gudbjornsson, B. ^{[6
,7
]}

Gron, K. L. ^{[2
,3
]}

Provan, S. Aarrestad ^{[8
]}

Michelsen, B. ^{[8
]}

Hetland, M. L. ^{[2
,3
]}

Wallman, J. K. ^{[9
]}

Nordstrom, D. ^{[10
,11
]}

Trokovic, N. ^{[10
,11
]}

Love, T. ^{[6
]}

Krogh, N. Steen ^{[2
,3
]}

Askling, J. ^{[4
]}

Jacobsson, L. T. H. ^{[1
]}

Kristensen, L. E. ^{[5
]}

机构：

[1] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden

[2] COPECARE, Glostrup, Denmark

[3] DANBIO, Glostrup, Denmark

[4] Karolinska Inst, Stockholm, Sweden

[5] Frederiksberg & Bispebjerg Univ Hosp, Parker Inst, Copenhagen, Denmark

[6] Univ Iceland, Reykjavik, Iceland

[7] ICEBIO, Reykjavik, Iceland

[8] Diakonhjemmet Hosp, Oslo, Norway

[9] Lund Univ, Lund, Sweden

[10] Univ Helsinki, ROB FIN, Helsinki, Finland

[11] Helsinki Univ Hosp, Helsinki, Finland

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷

关键词：

D O I：

10.1136/annrheumdis-2020-eular.881

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

THU0394

引用

页码：427 / 428

页数：2

共 50 条

[1] EFFECTIVENESS AND TREATMENT RETENTION OF TNF-INHIBITORS WHEN USED AS MONOTHERAPY VERSUS COMEDICATION WITH csDMARDs IN 15332 PATIENTS WITH PSORIATIC ARTHRITIS. DATA FROM THE EuroSpA COLLABORATION
Lindstrom, U.
Di Giuseppe, D.
Delcoigne, B.
Glintborg, B.
Jacobsson, L.
Askling, J.
Nissen, M. J.
[J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (05) : 1236 - 1237
[2] Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration
Lindstrom, Ulf
Di Giuseppe, Daniela
Delcoigne, Benedicte
Glintborg, Bente
Moller, Burkhard
Ciurea, Adrian
Pombo-Suarez, Manuel
Sanchez-Piedra, Carlos
Eklund, Kari
Relas, Heikki
Gudbjornsson, Bjorn
Love, Thorvardur Jon
Jones, Gareth T.
Codreanu, Catalin
Ionescu, Ruxandra
Nekvindova, Lucie
Zavada, Jakub
Atas, Nuh
Yolbas, Servet
Fagerli, Karen Minde
Michelsen, Brigitte
Rotar, Ziga
Tomsic, Matija
Iannone, Florenzo
Santos, Maria Jose
Avila-Ribeiro, Pedro
Ornbjerg, Lykke Midtboll
Ostergaard, Mikkel
Jacobsson, Lennart T. H.
Askling, Johan
Nissen, Michael J.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (11) : 1410 - 1418
[3] Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis
Lindstrom, Ulf
Glintborg, Bente
Di Giuseppe, Daniela
Jorgensen, Tanja Schjodt
Gudbjornsson, Bjorn
Gron, Kathrine Lederballe
Provan, Sella Aarrestad
Michelsen, Brigitte
Hetland, Merete Lund
Wallman, Johan K.
Nordstrom, Dan
Trokovic, Nina
Love, Thorvardur Jon
Krogh, Niels Steen
Askling, Johan
Jacobsson, Lennart T. H.
Kristensen, Lars Erik
[J]. RHEUMATOLOGY, 2021, 60 (08) : 3635 - 3645
[4] Switching Between TNF-Inhibitors in Psoriatic Arthritis: Data From the NOR-DMARD Study
Fagerli, Karen M.
Lie, Elisabeth
van der Heijde, Desiree
Heiberg, Marte S.
Lexberg, Ase S.
Mikkelsen, Knut
Rodevand, Erik
Kalstad, Synnove
Kvien, Tore K.
[J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1083 - S1083
[5] Secukinumab real world drug retention compared to TNF-alpha inhibitors in psoriatic arthritis
Eviatar, T.
Zisman, D.
Gendelman, O.
Reitblat, T.
Balbir-Gurman, A.
Mashiach, T.
Almog, R.
Elkayam, O.
[J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (01) : 15 - 23
[6] Effectiveness and drug survival of TNF-inhibitors in the treatment of psoriatic arthritis: A prospective cohort study
Aaltonen, Kalle
Heinonen, Arto
Joensuu, Jaana
Parmanne, Pinja
Karjalainen, Anna
Varjolahti-Lehtinen, Tuire
Uutela, Toini
Puurtinen-Vilkki, Maija
Arstila, Leena
Blom, Marja
Sokka, Tuulikki
Nordstrom, Dan
[J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2017, 46 (06) : 732 - 739
[7] A cost-efficacy comparison of TNF-inhibitors in the treatment of rheumatoid arthritis
Chiou, C
Malone, DC
Wanke, LA
Yu, EB
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 269 - 269
[8] Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries
Glintborg, Bente
Di Giuseppe, Daniela
Wallman, Johan K.
Provan, Sella A.
Nordstrom, Dan
Hokkanen, Anna-Mari
Osterlund, Jenny
Kristianslund, Eirik
Kvien, Tore K.
Gudbjornsson, Bjorn
Hetland, Merete Lund
Michelsen, Brigitte
Jacobsson, Lennart
Askling, Johan
Lindstrom, Ulf
[J]. RHEUMATOLOGY, 2023, 62 (02) : 647 - 658
[9] Perspectives on Treatment Burden for Methotrexate and TNF-inhibitors Among Psoriatic Arthritis and Rheumatoid Arthritis Patients: A Qualitative Study
Ogdie, Alexis
Shaw, Yomei
Almonte, Michele
Maksabedian, Ervant
Michaud, Kaleb
[J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
[10] REMISSION AND DRUG RETENTION RATES OF SECUKINUMAB IN 1549 PATIENTS WITH PSORIATIC ARTHRITIS TREATED IN ROUTINE CARE - POOLED DATA FROM THE OBSERVATIONAL EUROSPA RESEARCH COLLABORATION NETWORK
Michelsen, Brigitte
Brahe, Cecilie Heegaard
Jacobsson, Lennart T. H.
Nissen, Michael
Pombo-Suarez, Manuel
Mann, Herman
Rotar, Ziga
Sexton, Joe
Santos, Maria Jose
Nordstrom, Dan
Codreanu, Catalin
Gudbjornsson, Bjorn
Yilmaz, Sema
Iannone, Florenzo
Lindstrom, Ulf
Loft, Anne Gitte
Moeller, Burkhard
Sanchez-Piedra, Carlos
Pavelka, Karel
Tomsic, Matija
Kristianslund, Eirik
Santos, Helena
Hokkanen, Anna-Mari
Ionescu, Ruxandra
Love, Thorvardur Jon
Pehlivan, Yavuz
Sebastiani, Marco
Jones, Gareth T.
van der Horst-Bruinsma, Irene
Hyldstrup, Lise
Krogh, Niels Steen
Hetland, Merete L.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1281 - 1282

← 1 2 3 4 5 →